Medicines

Fulltext search

For help on how to get the results you want, see our search tips.

Search results

Categories

Human Remove Human filter

Medicine name

Active substance / international non-proprietary name (INN) / common name

Medicine

European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter Referrals Remove Referrals filter

Product number

Date of opinion

From:

To:

Referral name

Referral status

European Commission final decision Remove European Commission final decision filter Opinion provided by Committee for Medicinal Products for Human Use Remove Opinion provided by Committee for Medicinal Products for Human Use filter Under evaluation Remove Under evaluation filter

Referral safety status

Yes (20) Apply Yes filter

Referral type

Article 30 referrals Remove Article 30 referrals filter Article 20 procedures Remove Article 20 procedures filter Article 107 procedures (prior to July 2012) Remove Article 107 procedures (prior to July 2012) filter Article 13 referrals Remove Article 13 referrals filter Article 29(4) referrals (116) Apply Article 29(4) referrals filter Article 31 referrals (101) Apply Article 31 referrals filter Article 6(12) referrals (prior to January 2010) (21) Apply Article 6(12) referrals (prior to January 2010) filter Article 29 paediatrics (9) Apply Article 29 paediatrics filter Article 36 referrals (prior to July 2012) (9) Apply Article 36 referrals (prior to July 2012) filter Article 6(13) referrals (prior to January 2010) (5) Apply Article 6(13) referrals (prior to January 2010) filter Article 107i procedures (5) Apply Article 107i procedures filter Article 5(11) referrals (prior to January 2010) (2) Apply Article 5(11) referrals (prior to January 2010) filter

Referral reference number

Referral decision making model

PRAC-CHMP-EC (18) Apply PRAC-CHMP-EC filter

Referral authorisation model

Centrally authorised product(s) (20) Apply Centrally authorised product(s) filter Nationally authorised product(s) (3) Apply Nationally authorised product(s) filter

Referral PRAC recommendation

No further action (1) Apply No further action filter Risk minimisation measures (12) Apply Risk minimisation measures filter Suspension (3) Apply Suspension filter Variation (2) Apply Variation filter

Referral procedure start date

From:

To:

Referral PRAC recommendation date

From:

To:

Decision date

From:

To:

Medicine type

Accelerated assessment (2) Apply Accelerated assessment filter Additional monitoring (12) Apply Additional monitoring filter Conditional approval (1) Apply Conditional approval filter

Related medicine

Therapeutic area

Last updated

From:

To:

This week This month Last week Last month

First published

From:

To:

138 results

Remove all filtersRemove all filters

Categories Human Remove Human filter

Medicine European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter Referrals Remove Referrals filter

Referral status European Commission final decision Remove European Commission final decision filter Opinion provided by Committee for Medicinal Products for Human Use Remove Opinion provided by Committee for Medicinal Products for Human Use filter Under evaluation Remove Under evaluation filter

Referral type Article 30 referrals Remove Article 30 referrals filter Article 13 referrals Remove Article 13 referrals filter Article 107 procedures (prior to July 2012) Remove Article 107 procedures (prior to July 2012) filter Article 20 procedures Remove Article 20 procedures filter

Sort by

List item

Referral: Cozaar

losartan, Article 30 referrals
Status: European Commission final decision, opinion/position date: 24/04/2008, EC decision date: 03/09/2008, Last updated: 25/09/2008
List item

Referral: Cymevene

ganciclovir, associated names: Cymevan, Citovirax, Article 30 referrals
Status: European Commission final decision, opinion/position date: 25/02/2016, EC decision date: 28/04/2016, Last updated: 21/06/2016
List item

Referral: Daivobet

calcipotriol and betamethasone, associated names: Dovobet, Article 30 referrals
Status: European Commission final decision, opinion/position date: 22/07/2010, EC decision date: 30/09/2010, Last updated: 26/04/2011
List item

Referral: Diflucan

fluconazole, associated names: Fluconazole, Fungustatin, Fungata, Triflucan, Article 30 referrals
Status: European Commission final decision, opinion/position date: 23/06/2011, EC decision date: 02/09/2011, Last updated: 02/02/2012
List item

Referral: Diovan

valsartan, Article 30 referrals
Status: European Commission final decision, opinion/position date: 21/11/2008, EC decision date: 16/02/2009, Last updated: 13/03/2009
List item

Referral: Diovan Comp

valsartan and hydrochlorothiazide, Article 30 referrals
Status: European Commission final decision, opinion/position date: 19/03/2009, EC decision date: 26/05/2009, Last updated: 11/06/2009
List item

Referral: Durogesic and associated names

fentanyl, Article 30 referrals
Status: European Commission final decision, opinion/position date: 21/07/2016, EC decision date: 22/09/2016, Last updated: 19/10/2016
List item

Referral: Ecazide

captopril/hydrochlorothiazide, Article 30 referrals
Status: European Commission final decision, opinion/position date: 25/04/2002, EC decision date: 22/08/2002, Last updated: 19/09/2002
List item

Referral: SGLT2 inhibitors

canagliflozin, dapagliflozin,empagliflozin, associated names: Edistride, Ebymect, Xigduo, Vokanamet, Synjardy, Jardiance, Invokana, Forxiga, Article 20 procedures
Status: European Commission final decision, opinion/position date: 25/02/2016, EC decision date: 28/04/2016, Last updated: 18/05/2016
List item

Referral: Efexor

venlafaxine, Article 30 referrals
Status: European Commission final decision, opinion/position date: 24/07/2008, EC decision date: 28/11/2008, Last updated: 18/12/2008
List item

Referral: Efexor depot

venlafaxine, Article 30 referrals
Status: European Commission final decision, opinion/position date: 24/07/2008, EC decision date: 28/11/2008, Last updated: 20/12/2008
List item

Referral: EMLA cream and associated names

lidocaine / prilocaine, Article 30 referrals
Status: European Commission final decision, opinion/position date: 25/09/2014, EC decision date: 28/11/2014, Last updated: 15/01/2015
List item

Referral: Escitalopram

escitalopram, Article 30 referrals
Status: Opinion provided by Committee for Medicinal Products for Human Use, opinion/position date: 18/02/2010, Last updated: 29/09/2010
List item

Referral: Esmya

ulipristal acetate, associated names: Esmya, Article 20 procedures
Status: European Commission final decision, opinion/position date: 31/05/2018, EC decision date: 26/07/2018, Last updated: 08/08/2018
List item

Referral: Etopophos

etoposide phosphate, Article 30 referrals
Status: European Commission final decision, opinion/position date: 21/04/2017, EC decision date: 26/06/2017, Last updated: 14/07/2017
List item

Referral: Famvir

famciclovir, associated names: Famciclovir-Sandoz, Famciclovir-SB, Famciclovir-SB Zoster, Famvir Zoster and Oravir, Article 30 referrals
Status: European Commission final decision, opinion/position date: 22/04/2010, EC decision date: 27/07/2010, Last updated: 09/09/2011
List item

Referral: Femara

letrozole, associated names: Femar, Fémara, Loxifan, Article 30 referrals
Status: European Commission final decision, opinion/position date: 15/03/2012, EC decision date: 22/05/2012, Last updated: 12/06/2012
List item

Referral: Flolan

epoprostenol, associated names: Epoprostenol, Article 30 referrals
Status: European Commission final decision, opinion/position date: 24/05/2012, EC decision date: 08/08/2012, Last updated: 14/09/2012
List item

Referral: Floxyfral

fluvoxamine, Article 30 referrals
Status: European Commission final decision, opinion/position date: 18/01/2002, EC decision date: 30/05/2002, Last updated: 25/07/2002
List item

Referral: Fortum

ceftazidime, associated names: Cefortam, Glazidim, Panzim, Solvetan, Article 30 referrals
Status: European Commission final decision, opinion/position date: 21/10/2010, EC decision date: 13/01/2011, Last updated: 22/10/2010
List item

Referral: Engerix B

recombinant hepatitis B vaccine, Article 30 referrals
Status: European Commission final decision, opinion/position date: 13/04/2000, EC decision date: 28/08/2000, Last updated: 28/08/2000
List item

Referral: Gemzar

gemcitabine, Article 30 referrals
Status: European Commission final decision, opinion/position date: 26/06/2008, EC decision date: 23/09/2008, Last updated: 06/10/2008
List item

Referral: Glucophage/Glucophage Forte/Risidon/Dianben

metformin, Article 30 referrals
Status: European Commission final decision, opinion/position date: 19/10/2000, EC decision date: 06/02/2001, Last updated: 07/02/2001
List item

Referral: Haldol and associated names

haloperidol, associated names: Aloperidin, Haldol-Janssen, Serenase, Article 30 referrals
Status: European Commission final decision, opinion/position date: 23/02/2017, EC decision date: 28/04/2017, Last updated: 05/05/2017
List item

Referral: Haldol Decanoate and associated names

haloperidol decanoate, associated names: Haldol Decanoat, Haldol Decanoas, Serenase Dekanoat, Serenase Depot, Haldol - Janssen Decanoat Depot, Haldol Decanoato, Haldol Depot, Article 30 referrals
Status: European Commission final decision, opinion/position date: 23/02/2017, EC decision date: 28/04/2017, Last updated: 11/05/2017

Load more

138 results

Referral: Cozaar

Referral: Cymevene

Referral: Daivobet

Referral: Diflucan

Referral: Diovan

Referral: Diovan Comp

Referral: Durogesic and associated names

Referral: Ecazide

Referral: SGLT2 inhibitors

Referral: Efexor

Referral: Efexor depot

Referral: EMLA cream and associated names

Referral: Escitalopram

Referral: Esmya

Referral: Etopophos

Referral: Famvir

Referral: Femara

Referral: Flolan

Referral: Floxyfral

Referral: Fortum

Referral: Engerix B

Referral: Gemzar

Referral: Glucophage/Glucophage Forte/Risidon/Dianben

Referral: Haldol and associated names

Referral: Haldol Decanoate and associated names